Motif ID: Hoxc9
Z-value: 0.565
![logo of Hoxc9](../logos/Hoxc9.png)
Transcription factors associated with Hoxc9:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Hoxc9 | ENSMUSG00000036139.6 | Hoxc9 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hoxc9 | mm10_v2_chr15_+_102977032_102977032 | -0.30 | 1.4e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 7.9 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) pulmonary myocardium development(GO:0003350) subthalamus development(GO:0021539) subthalamic nucleus development(GO:0021763) left lung morphogenesis(GO:0060460) pulmonary vein morphogenesis(GO:0060577) superior vena cava morphogenesis(GO:0060578) |
0.4 | 1.6 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.3 | 1.7 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 0.7 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.2 | 0.5 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.2 | 1.2 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.4 | GO:0003219 | atrioventricular node development(GO:0003162) cardiac right ventricle formation(GO:0003219) |
0.1 | 0.3 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
0.1 | 0.7 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.3 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
0.1 | 0.5 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 1.5 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) cellular response to fatty acid(GO:0071398) |
0.1 | 3.0 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 1.6 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 1.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 1.2 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 1.8 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.1 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.7 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.3 | GO:0071914 | prominosome(GO:0071914) |
0.1 | 0.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.3 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 1.7 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.7 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 8.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 1.2 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.2 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.0 | 0.3 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 1.6 | GO:0016607 | nuclear speck(GO:0016607) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.7 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.2 | 0.7 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.2 | 3.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 7.9 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.7 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.0 | 1.6 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.0 | 0.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 1.5 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.4 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 0.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.0 | 0.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 1.2 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.3 | GO:0042805 | actinin binding(GO:0042805) |